Publications by authors named "Panagiotakaki E"

The Houge type of X-linked syndromic intellectual developmental disorder (MRXSHG) encompasses a spectrum of neurodevelopmental disorders characterized by intellectual disability (ID), language/speech delay, attention issues, and epilepsy. These conditions arise from hemizygous or heterozygous deletions, along with point mutations, affecting CNKSR2, a gene located at Xp22.12.

View Article and Find Full Text PDF
Article Synopsis
  • Alternating hemiplegia of childhood (AHC) is a rare disorder linked with neurological and heart issues, particularly the ATP1A3-D801N variant, which causes a shorter QT interval and arrhythmia risks.
  • A study at Duke University evaluated heart rate (HR) and QT intervals in individuals with AHC, revealing that those with the variant had less QT prolongation at lower HR compared to healthy controls.
  • The findings suggest that individuals with ATP1A3-D801N show abnormal heart rhythms, indicating a need for closer monitoring and intervention for potential heart issues.
View Article and Find Full Text PDF
Article Synopsis
  • An 11-year-old Polish girl experienced episodes of decreased consciousness, paralysis, movement disorders, slurred speech, swallowing difficulties, and abnormal eye movements, but extensive testing did not identify a clear cause.
  • Genetic testing revealed a new mutation in the ATP1A3 gene, which has been associated with various neurological disorders, including epilepsy.
  • Video-EEG monitoring confirmed non-epileptic causes of her hemidystonia episodes, but also showed signs of a specific type of epilepsy related to her ATP1A3 mutation, highlighting the overlap of symptoms from different ATP1A3-related syndromes.
View Article and Find Full Text PDF

Objective: YWHAG variant alleles have been associated with a rare disease trait whose clinical synopsis includes an early onset epileptic encephalopathy with predominantly myoclonic seizures, developmental delay/intellectual disability, and facial dysmorphisms. Through description of a large cohort, which doubles the number of reported patients, we further delineate the spectrum of YWHAG-related epilepsy.

Methods: We included in this study 24 patients, 21 new and three previously described, with pathogenic/likely pathogenic variants in YWHAG.

View Article and Find Full Text PDF

Background: Many alternating hemiplegia of childhood (AHC) patients have received Cannabidiol (CBD) but, to our knowledge, there are no published data available.

Goals: Test the hypothesis that CBD has favorable effects on AHC spells.

Methods: Retrospective review of available data of AHC patients who received CBD.

View Article and Find Full Text PDF

Alternating hemiplegia of childhood (AHC) is a rare neurodevelopment disorder that is typically characterized by debilitating episodic attacks of hemiplegia, seizures, and intellectual disability. Over 85% of individuals with AHC have a de novo missense variant in ATP1A3 encoding the catalytic α3 subunit of neuronal NaK ATPases. The remainder of the patients are genetically unexplained.

View Article and Find Full Text PDF

Here, we describe the process of development of the methodology for an international multicenter natural history study of alternating hemiplegia of childhood as a prototype disease for rare neurodevelopmental disorders. We describe a systematic multistep approach in which we first identified the relevant questions about alternating hemiplegia of childhood natural history and expected challenges. Then, based on our experience with alternating hemiplegia of childhood and on pragmatic literature searches, we identified solutions to determine appropriate methods to address these questions.

View Article and Find Full Text PDF

Background: Developing methods to record Alternating Hemiplegia of Childhood (AHC) spells is essential for clinical trials and patient care.

Objectives: Test the following hypotheses: 1) Video-library training improves participants' ability to correctly identify AHC spells. 2) A custom-designed event-calendar with weekly reviews results in consistent documentation of such events over time.

View Article and Find Full Text PDF

Although a striking female preponderance has been consistently reported in epilepsy with eyelid myoclonia (EEM), no study has specifically explored the variability of clinical presentation according to sex in this syndrome. Here, we aimed to investigate sex-specific electroclinical differences and prognostic determinants in EEM. Data from 267 EEM patients were retrospectively analyzed by the EEM Study Group, and a dedicated multivariable logistic regression analysis was developed separately for each sex.

View Article and Find Full Text PDF

Objective: Epilepsy with eyelid myoclonia (EEM) has been associated with marked clinical heterogeneity. Early epilepsy onset has been recently linked to lower chances of achieving sustained remission and to a less favorable neuropsychiatric outcome. However, much work is still needed to better delineate this epilepsy syndrome.

View Article and Find Full Text PDF

Brain voltage-gated sodium channel NaV1.1 (SCN1A) loss-of-function variants cause the severe epilepsy Dravet syndrome, as well as milder phenotypes associated with genetic epilepsy with febrile seizures plus. Gain of function SCN1A variants are associated with familial hemiplegic migraine type 3.

View Article and Find Full Text PDF

Background And Objectives: Eyelid myoclonia (EM) with absences (EMA) is a generalized epilepsy syndrome with a prognosis and clinical characteristics that are still partially undefined. We investigated electroclinical endophenotypes and long-term seizure outcome in a large cohort of patients with EMA.

Methods: In this multicenter retrospective study, patients with EMA with ≥5 years of follow-up were included.

View Article and Find Full Text PDF
Article Synopsis
  • The EPIGENE network, formed in 2014 by a group of specialists in genetics and neurology, aims to enhance the diagnosis of Mendelian epileptic disorders in France through advanced sequencing techniques.
  • Since its creation, the network has expanded to include more centers, resulting in the development of a multigene panel that has grown from 68 to 144 genes, with a significant diagnostic success rate of 31% from over 4,000 analyzed cases.
  • Looking ahead, the network plans to offer whole-genome sequencing for young patients with severe epilepsy as part of the upcoming 2025 French Genomic Medicine Plan, fostering collaborations with the rare epilepsies reference center.
View Article and Find Full Text PDF
Article Synopsis
  • Alternating hemiplegia of childhood is a rare neurodevelopmental disorder linked to genetic mutations, showing potential disease progression despite limited systematic studies.* -
  • A study involving 42 US patients found that as patients age, there is a mild worsening in non-paroxysmal disability scores, with early-life disability scores predicting later outcomes.* -
  • Similar findings were observed in a French cohort and in a mouse model, indicating that age is a significant factor in the progression of the disorder.*
View Article and Find Full Text PDF

Background: Previous functional magnetic resonance imaging (fMRI) studies have identified brain systems underlying different components of working memory (WM) in healthy subjects. The aim of this study was to compare the functional integrity of these neural networks in children with self-limited childhood epilepsy with centro-temporal spikes (ECTS) as compared to healthy controls, using a verbal working memory task (WMT).

Methods: Functional MRI of WM in seventeen 6-to-13 year-old children, diagnosed with ECTS, and 17 sex- and age-matched healthy controls were conducted at 3 T.

View Article and Find Full Text PDF

Objective: To define the risks and consequences of cardiac abnormalities in -related syndromes.

Methods: Patients meeting clinical diagnostic criteria for rapid-onset dystonia-parkinsonism (RDP), alternating hemiplegia of childhood (AHC), and cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss (CAPOS) with genetic analysis and at least 1 cardiac assessment were included. We evaluated the cardiac phenotype in an knock-in mouse (Mashl) to determine the sequence of events in seizure-related cardiac death.

View Article and Find Full Text PDF

Objective: To assess nonparoxysmal movement disorders in mutation-positive patients with alternating hemiplegia of childhood (AHC).

Methods: Twenty-eight patients underwent neurologic examination with particular focus on movement phenomenology by a specialist in movement disorders. Video recordings were reviewed by another movement disorders specialist and data were correlated with patients' characteristics.

View Article and Find Full Text PDF

Objectives: To evaluate the predictive factors for status epilepticus (SE) in neonates and prognostic factors for patient outcomes in newborns suffering either isolated seizures or SE.

Methods: A retrospective single-center study from January 2010 to December 2014, included 91 newborns who had neonatal seizures. Among them, 50 newborns experienced SE and 41 newborns presented isolated seizures only.

View Article and Find Full Text PDF
Article Synopsis
  • The article initially spelled the author's name incorrectly as Erik Niks instead of Erik H. Niks.
  • This error has been corrected in the PDF and HTML versions of the article.
  • The correction ensures that the author's name is accurately represented moving forward.
View Article and Find Full Text PDF